MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Pelizaeus Merzbacher like disease (PMLD): Neuroradiological Phenotyping

    K. Shah, M. Shah (Mumbai, India)

    Objective: To present an unusual case report. Background: Pelizaeus Merzbacher like disease (PMLD) is a hypomyelination disorder, usually manifesting in neonatal or an early infantile…
  • 2026 International Congress

    Motor Fluctuations and Dyskinesias in LRRK2-Associated Parkinson’s Disease

    A. Agrebaoui, R. Zouari, A. Mousli, F. Nabli, D. Ben Mohamed, A. Rachdi, MZ. Saied, S. Ben Sassi (Tunis, Tunisia)

    Objective: To characterize motor fluctuations and dyskinesias in patients with LRRK2-associated Parkinson’s disease. Background: Motor complications, including dyskinesias and motor fluctuations, are hallmarks of advanced…
  • 2026 International Congress

    Unveiling the unusual: PNMA2 paraneoplastic syndrome

    M. Shah, K. Shah, B. Patel (Mumbai, India)

    Objective: To present a rare case report Background: A 69 year old woman presented with progressive ptosis, change in voice (hypophonia), dysphagia, generalised weakness with…
  • 2026 International Congress

    Age-related characteristics of the clinical progression of Parkinson’s disease

    B. Muminov, R. Matmurodov, B. Amonov, S. Jumanazarova (Tashkent, Uzbekistan)

    Objective: To analysis of the rate of progression of the disease in PD according to the age of patients. Background: Although Parkinson's disease (PD) is…
  • 2026 International Congress

    SCN8A-Related Disorders: Expanding the Movement Disorder Phenotype Through a Case Report and Literature Review

    R. Alkhodair, H. Alfaris, S. Yoganathan, C. Gorodetsky (Toronto, Canada)

    Objective: To describe a pediatric case with a pathogenic SCN8A variant who presented with neurodevelopmental delay, seizure and prominent cerebellum signs, along with providing a…
  • 2026 International Congress

    Acrostic for the differential diagnosis of atypical Parkinsonian

    L. Ortega-Bolaños, V. Martinez-Villota, E. Gatto, D. Bolaños Ortega, K. Ortega Dorado, C. Hurtado Gonzalez, J. Fernandez Boccazzi (CALI, Colombia)

    Objective: Evaluating the usefulness of clinical acrostic for the differential diagnosis of atypical Parkinsonian syndromes Background: Differentiate Parkinson’s disease from atypical parkinsonian syndromes  is challenging…
  • 2026 International Congress

    Phenotype – lesion correlation in post-stroke movement disorders: Lessons learnt from two cases

    A. Mukherjee, S. Pandey (Kolkata, India)

    Objective: To understand the phenotype-lesion correlation in post-stroke movement disorders (PSMD) from insights gained from two cases. Background: PSMD is an important complication after stroke,…
  • 2026 International Congress

    Safety and Feasibility of Repetitive Transcranial Magnetic Stimulation in Dementia with Lewy Bodies: An Ongoing Proof-of-Concept Study

    K. Baik, M. Park (Seoul, Republic of Korea)

    Objective: To investigate the safety and potential cognitive benefits of repetitive transcranial magnetic stimulation (rTMS) in patients with dementia with Lewy bodies (DLB) using a…
  • 2026 International Congress

    ANK2 Mutations Associated with a Myoclonus-Dystonia Phenotype: Expanding the Neurological Spectrum of Ankyrin-B Dysfunction

    A. Lackova, M. Zech, J. Necpal, Z. Brezna, V. Han, K. Kulcsarova, M. Ostrozovicova, T. Svorenova, Z. Gdovinova, M. Skorvanek (Košice, Slovakia)

    Objective: To deeply characterize the clinical and genetic spectrum of ANK2-related hyperkinetic movement disorders and expand their recognized link to myoclonus-dystonia phenotype. Background: The ANK2…
  • 2026 International Congress

    Improving Community Access to Parkinson’s Disease Clinical Trials: Protocol for a Regional Navigation Toolkit in Southern California

    A. Singh, J. Adrissi, A. Mendizabal, D. Lim, A. Shurlock, D. Thordarson (Los Angeles, USA)

    Objective: To develop and pilot a regional Clinical Trials Navigation Toolkit to improve community neurologist awareness of Parkinson’s disease (PD) clinical trials and support equitable…
  • « Previous Page
  • 1
  • …
  • 199
  • 200
  • 201
  • 202
  • 203
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley